STOCK TITAN

FEMASYS INC Financials

FEMY
Trailing 12 months to June 30, 2026
Revenue $2.3M +21.9% YoY
Net Income -$11.8M +44.0% YoY
EPS (Diluted) -$0.47 FY2025 annual
Free Cash Flow -$18.1M +11.3% YoY
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

FEMASYS INC (FEMY) reported $2.3M in revenue over the twelve months to Jun 30, 2026, up 21.9% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI FEMY FY2025

External financing, not internal cash generation, is carrying a development-stage business whose revenue growth has not yet covered its cost base.

Revenue rose 41.0% while operating loss stayed near $17.6M, indicating incremental sales absorbed part of the fixed R&D and administrative base rather than translating into profitability. Gross margin slipped from 66.6% to 62.0%, so the improvement in operating loss came despite weaker unit economics, not from richer margins.

The near match between FY2025 net loss of $18.6M and operating cash outflow of $18.7M means reported losses are translating directly into cash consumption, with little earnings-quality cushion. Capital spending was only $525K, while inventory reached $5.7M, making the cash drain more working-capital-heavy than investment-heavy.

FY2025 financing provided $25.1M against $18.7M of operating cash use, making outside capital the bridge to continued operations. With cash below total liabilities and debt-to-equity at 2.5x, the balance sheet is more financing-dependent than the earlier cash-rich, lightly leveraged structure.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 43 / 100
Financial Health Score 43/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of FEMASYS INC's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
20
Dilution
14
R&D Intensity
70
Revenue Progress
85
Burn Trend
21
Balance Sheet
48
Altman Z-Score Distress
-10.72

FEMASYS INC scores -10.72, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($26.8M) relative to total liabilities ($14.9M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
2/8

FEMASYS INC passes 2 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality No Cash Backing
N/A

FEMASYS INC reported a net loss of $18.6M while operations used $18.7M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

FEMASYS INC reported an operating loss of $17.6M against $1.9M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$2.3M
YoY+40.8%
5Y CAGR+17.2%

FEMASYS INC generated $2.3M in revenue in fiscal year 2025. This represents an increase of 40.8% from the prior year.

EBITDA
-$17.2M
YoY+1.4%

FEMASYS INC's EBITDA was -$17.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 1.4% from the prior year.

Net Income
-$18.6M
YoY+1.0%

FEMASYS INC reported -$18.6M in net income in fiscal year 2025. This represents an increase of 1.0% from the prior year.

EPS (Diluted)
-$0.47

FEMASYS INC earned -$0.47 per diluted share (EPS) in fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow
-$19.2M
YoY+4.9%

FEMASYS INC recorded an outflow of $19.2M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents an increase of 4.9% from the prior year.

Cash & Debt
$9.3M
YoY+168.5%
5Y CAGR+22.8%

FEMASYS INC held $9.3M in cash as of fiscal year 2025; long-term debt is not reported for that period.

Shares Outstanding
60M

FEMASYS INC had 60M shares outstanding in fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
62.0%
YoY-4.6pp
5Y CAGR-8.5pp

FEMASYS INC's gross margin was 62.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 4.6 percentage points from the prior year.

Return on Equity
-317.4%
YoY+499.2pp

FEMASYS INC's ROE was -317.4% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 499.2 percentage points from the prior year.

Operating Margin

Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

R&D Spending
$7.6M
YoY-7.8%
5Y CAGR+12.9%

FEMASYS INC invested $7.6M in research and development in fiscal year 2025. This represents a decrease of 7.8% from the prior year.

Capital Expenditures
$525K
YoY-31.1%
5Y CAGR+128.9%

FEMASYS INC invested $525K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 31.1% from the prior year.

Share Buybacks

Not reported for fiscal year 2025.

FEMY Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

FEMY quarterly income statement
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Revenue$332K-21.9%$425K-47.8%$813K+11.5%$729K+78.2%$409K+19.9%$341K-41.3%$582K+4.8%$555K
Cost of Revenue$142K-10.2%$159K-47.7%$303K+3.2%$294K+85.8%$158K+34.9%$117K-39.1%$192K+0.8%$191K
Gross Profit$189K-28.9%$266K-47.8%$510K+17.2%$436K+73.5%$251K+12.1%$224K-42.4%$389K+6.9%$364K
R&D Expenses$1.9M+48.7%$1.3M-27.8%$1.8M+31.2%$1.4M-2.3%$1.4M-52.4%$3.0M+37.0%$2.2M-5.9%$2.3M
SG&A Expenses$1.9M+8.4%$1.8M-2.5%$1.8M+23.7%$1.5M-8.6%$1.6M-6.1%$1.7M+2.5%$1.7M+9.8%$1.5M
Operating Income-$5.1M-19.9%-$4.2M+8.6%-$4.6M-26.5%-$3.7M+5.1%-$3.9M+29.5%-$5.5M-15.6%-$4.7M+7.7%-$5.1M
Interest Expense$186K+5.3%$177K-56.7%$408K-23.3%$532K+8.3%$492K+7.0%$459K+4.3%$440K+6.6%$413K
Income Tax$865$0-100.0%$5K$0$0+100.0%-$4K-141.1%$10K+780.3%$1K
Net Income-$4.5M-628.2%$846K+121.4%-$4.0M+5.8%-$4.2M+8.5%-$4.6M+22.2%-$5.9M-15.1%-$5.1M+5.3%-$5.4M
EPS (Diluted)-$1.33$0.00+100.0%-$0.01-$0.10-$3.18-$0.230.0%-$0.23+4.2%-$0.24

FEMY Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

FEMY quarterly balance sheet
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Total Assets$12.3M-25.5%$16.5M-20.4%$20.7M+27.2%$16.3M+18.2%$13.8M+3.8%$13.3M+6.7%$12.4M-20.1%$15.6M
Current Assets$8.3M-32.5%$12.3M-25.0%$16.5M+34.4%$12.2M+25.6%$9.8M+6.8%$9.1M+13.8%$8.0M-29.0%$11.3M
Cash & Equivalents$1.4M-73.2%$5.4M-41.9%$9.3M+102.8%$4.6M+42.0%$3.2M-15.8%$3.8M+10.7%$3.5M-54.6%$7.6M
Inventory$6.2M+1.4%$6.1M+6.4%$5.7M-0.8%$5.8M+10.5%$5.2M+35.5%$3.9M+26.8%$3.0M+57.2%$1.9M
Accounts Receivable$151K-12.3%$172K-72.1%$617K+7.8%$572K+124.8%$255K+9.0%$234K-52.2%$488K+29.1%$378K
Total Liabilities$8.3M-10.3%$9.2M-38.0%$14.9M+26.6%$11.7M-4.4%$12.3M+8.8%$11.3M+11.2%$10.1M+5.5%$9.6M
Current Liabilities$3.9M+23.2%$3.2M-13.2%$3.6M-65.5%$10.5M-3.8%$11.0M+11.4%$9.8M+14.7%$8.6M+199.3%$2.9M
Total Equity$4.0M-44.7%$7.3M+24.2%$5.9M+28.8%$4.6M+202.3%$1.5M-24.5%$2.0M-13.4%$2.3M-61.4%$6.0M
Retained Earnings-$149.4M-3.1%-$145.0M+0.6%-$145.8M-2.8%-$141.9M-3.0%-$137.7M-3.4%-$133.1M-4.6%-$127.2M-4.2%-$122.1M

Not reported in any period shown, so not listed: Goodwill, Long-Term Debt.

FEMY Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

FEMY quarterly cash flow statement
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Operating Cash Flow-$3.9M+5.0%-$4.1M+1.0%-$4.2M+22.3%-$5.4M-23.8%-$4.4M+8.7%-$4.8M+6.1%-$5.1M+7.3%-$5.5M
Capital Expenditures$9K-88.1%$79K-43.4%$140K-28.0%$194K+106.2%$94K-2.5%$97K-9.5%$107K-73.8%$408K
Free Cash Flow-$3.9M+6.6%-$4.2M+2.4%-$4.3M+22.5%-$5.6M-25.5%-$4.4M+8.5%-$4.9M+6.2%-$5.2M+11.9%-$5.9M
Investing Cash Flow-$22K+72.0%-$79K+59.8%-$197K+18.0%-$240K-147.3%-$97K-0.4%-$97K+12.7%-$111K+74.9%-$440K
Financing Cash Flow$15K-95.5%$342K-96.2%$9.1M+30.1%$7.0M+81.4%$3.8M-26.4%$5.2M+409.9%$1.0M$0
Share BuybacksN/AN/AN/AN/AN/A$162K+437.5%$30K$0

Not reported in any period shown, so not listed: Dividends Paid.

FEMY Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

FEMY quarterly financial ratios
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Gross Margin57.1%-5.6pp62.7%-0.1pp62.7%+3.0pp59.7%-1.6pp61.4%-4.3pp65.6%-1.3pp66.9%+1.3pp65.6%
Operating Margin-1526.7%-994.0%-568.3%-500.9%-941.1%-1600.1%-812.0%-922.4%
Net Margin-1346.8%199.1%-485.7%-575.1%-1120.5%-1727.9%-881.0%-974.7%
Return on Equity-110.9%-122.5pp11.6%+78.9pp-67.3%+24.8pp-92.1%+212.1pp-304.2%-8.9pp-295.3%-73.0pp-222.3%-131.7pp-90.6%
Return on Assets-36.4%-41.5pp5.1%+24.2pp-19.1%+6.7pp-25.8%+7.5pp-33.3%+11.1pp-44.4%-3.2pp-41.2%-6.5pp-34.7%
Current Ratio2.14-1.8x3.91-0.6x4.53+3.4x1.16+0.3x0.890.0x0.930.0x0.93-3.0x3.94
Debt-to-Equity2.05+0.8x1.26-1.3x2.530.0x2.58-5.6x8.14+2.5x5.65+1.2x4.40+2.8x1.61
FCF Margin-1188.9%-993.8%-531.7%-765.3%-1086.6%-1424.6%-890.9%-1060.1%

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Similar Companies

Frequently Asked Questions

What is FEMASYS INC's annual revenue?

FEMASYS INC (FEMY) reported $2.3M in total revenue for fiscal year 2025. This represents a 40.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is FEMASYS INC's revenue growing?

FEMASYS INC (FEMY) revenue grew by 40.8% year-over-year, from $1.6M to $2.3M in fiscal year 2025.

Is FEMASYS INC profitable?

No, FEMASYS INC (FEMY) reported a net income of -$18.6M in fiscal year 2025.

FEMASYS INC (FEMY) reported diluted earnings per share of -$0.47 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

FEMASYS INC (FEMY) had EBITDA of -$17.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

FEMASYS INC (FEMY) had a gross margin of 62.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

FEMASYS INC (FEMY) has a return on equity of -317.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

FEMASYS INC (FEMY) recorded an outflow of $19.2M in free cash flow during fiscal year 2025. This represents a 4.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

FEMASYS INC (FEMY) recorded an outflow of $18.7M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

FEMASYS INC (FEMY) had $20.7M in total assets as of fiscal year 2025, including both current and long-term assets.

FEMASYS INC (FEMY) invested $525K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

FEMASYS INC (FEMY) invested $7.6M in research and development during fiscal year 2025.

FEMASYS INC (FEMY) had 60M shares outstanding as of fiscal year 2025.

FEMASYS INC (FEMY) had a current ratio of 4.53 as of fiscal year 2025, which is generally considered healthy.

FEMASYS INC (FEMY) had a debt-to-equity ratio of 2.53 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

FEMASYS INC (FEMY) had a return on assets of -89.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

At the end of fiscal year 2025, FEMASYS INC (FEMY) held $9.3M in cash, cash equivalents and investments, and reported an operating cash outflow of $18.7M over that year. Dividing the one by the other, the reported balance equals about 6 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

FEMASYS INC (FEMY) has an Altman Z-Score of -10.72, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

FEMASYS INC (FEMY) has a Piotroski F-Score of 2 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

FEMASYS INC (FEMY) reported a net loss of $18.6M while operations used $18.7M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

FEMASYS INC (FEMY) reported an operating loss of $17.6M against $1.9M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

FEMASYS INC (FEMY) scores 43 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top